Advertisement

New Vaccines and Chemotherapy

  • Edouard Kurstak
  • R. G. Marusyk
  • F. A. Murphy
  • M. H. V. Van Regenmortel

Part of the Applied Virology Research book series (AOTP, volume 1)

Table of contents

  1. Front Matter
    Pages i-xxi
  2. Introduction

    1. Joseph L. Melnick
      Pages 1-14
  3. The New Generation of Virus Vaccines and Their Immunogenicity

    1. Front Matter
      Pages 15-15
    2. W. C. Leung, E. K. Manavathu, J. Zwaagstra, K. Suryanarayana, S. E. Hasnain, M. F. K. Leung
      Pages 25-30
    3. C. Yong Kang, Thierry Vernet, David Y. Thomas
      Pages 31-42
    4. Akio Nomoto, Michinori Kohara, Shusuke Kuge, Shinobu Abe, Bert L. Semler, Toshihiko Komatsu et al.
      Pages 43-54
    5. T. Vesikari, E. Isolauri, T. Ruuska, A. Delem, F. E. André
      Pages 55-62
    6. T. J. Wiktor, M. P. Kieny, R. Lathe
      Pages 69-90
  4. Vaccination with Synthetic Peptides

    1. Front Matter
      Pages 91-91
    2. F. Brown
      Pages 93-106
    3. A. R. Neurath, S. B. H. Kent, N. Strick, K. Parker
      Pages 107-128
    4. P. Frenchick, M. I. Sabara, M. K. Ijaz, L. A. Babiuk
      Pages 141-151
  5. Quality Control, Potency, and Standardization of Viral Vaccines

    1. Front Matter
      Pages 153-153
    2. J. Furesz, D. W. Boucher, G. Contreras
      Pages 155-171
    3. J. M. Wood, G. C. Schild, P. D. Minor, D. I. Magrath, Jennifer Mumford, R. G. Webster
      Pages 173-186
    4. Morag Ferguson, Valerie Seagroatt, G. C. Schild
      Pages 187-193
    5. A. Goudeau, F. Dubois, J. Klein, A. Godefroy, J. Huchet, Y. Brossard et al.
      Pages 195-208
    6. L. Mellander, B. Carlsson, L. Å. Hanson, F. Jalil, A. L. van Wezel, S. Zaman
      Pages 209-215
  6. Antiviral Chemotherapy

    1. Front Matter
      Pages 217-217
    2. M. Kende, D. J. Gangemi, W. Lange, D. A. Eppstein, J. Kreuter, P. G. Canonico
      Pages 241-264
    3. G. Schuster
      Pages 265-283
    4. A. J. Hansen
      Pages 285-299
  7. Back Matter
    Pages 301-306

About this book

Introduction

Viral Vaccines Joseph L. Melnick As with history in general, the history of vaccines needs to be reexamined and updated. My task is to look back to see what has been successful and to look forward to see what remains to be accomplished in the prevention of viral diseases by vaccines. Also, I shall refer to the pertinent material discussed at two recent conferences of the Institute of Medicine, National Academy of Sciences, on virus vaccines under development and their target populations in the United States (1985b) and in developing countries (1986). These reports, plus a third on Vaccine Supply and Innovation (1985a), should be required reading for all those in both the public and the private sector who have a responsibility or interest in vaccines for the prevention of human disease. It has been through the development and use of vaccines that many viral diseases have been brought under control. The vaccines consist either of infectious living attenu­ ated viruses or of noninfectious killed viruses or subviral antigens. When we look at the record, it is the live vaccines that have given the great successes in controlling diseases around the world. Examples are smallpox, yellow fever, poliomyelitis, measles, mumps, and rubella.

Keywords

Antigen chemotherapy development diseases lake research vaccine virology virus

Editors and affiliations

  • Edouard Kurstak
    • 1
  • R. G. Marusyk
    • 2
  • F. A. Murphy
    • 3
  • M. H. V. Van Regenmortel
    • 4
  1. 1.University of MontrealMontrealCanada
  2. 2.University of AlbertaEdmontonCanada
  3. 3.Centers for Disease ControlAtlantaUSA
  4. 4.Institute of Molecular and Cellular BiologyStrasbourgFrance

Bibliographic information